I would be interested to know how many have signed the petition at Change.org targeting Gilead Sciences (GS-7977) to partner with Bristol-Myers (BMS-790052 daclatasvir) and to put "patients before profits". Excerpts pasted below from various searches on the internet:
"Gilead, Bristol Hep C Drug Data at EASL: 100% Cure Rate with Bristol's phase II study of daclatasvir plus Gilead's GS-7977 in patients with genotypes 1, 2, and 3: SVR4 (early cure) rate in the genotype 1 patients: 100%. In genotype 2/3 patients, the SVR4 rate was 91%."
"But the combination might not find its way to the market because one pill is owned by Gilead Sciences and the other by Bristol-Myers Squibb. The companies have not agreed to collaborate, to the chagrin of some doctors."
"Dr. Douglas J. Manion, a senior vice president for Bristol-Myers, said his company was “keen” on working with Gilead but that “thus far, they have been unwilling to engage in that collaboration.”
If you have not signed it, I am curious to know your reasons. I have been following this forum since I was diagnosed last September, and I have spent hundreds, probably thousands of hours searching for treatment without the side effects of interferon and/or ribavirin.. And now there appears to be a 100% early CURE rate for GT1s without interferon OR ribavirin, and a 91% early CURE rate for GT3s (my genotype)...with minimal side effects (nausea, headache, fatigue).
Thank you all in advance for your responses.
Link to petition:
http://www.change.org/petitions/gilead-sciences-a-phase-iii-collaboration-for-the-treatment-of-hepatitis-c
Warmest Regards,
Margaret